Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: A translational research experience

Alessandro Passardi, Ilaria Massa, Wainer Zoli, Lorenzo Gianni, Carlo Milandri, Federica Zumaglini, Oriana Nanni, Roberta Maltoni, Giovanni Luca Frassineti, Dino Amadori

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: A translational research experience'. Together they form a unique fingerprint.

Medicine & Life Sciences